{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:36:24Z","timestamp":1785411384057,"version":"3.56.0"},"reference-count":139,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Kirk Kerkorian School of Medicine, UNLV"},{"id":[{"id":"https:\/\/ror.org\/0406gha72","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCDD"],"abstract":"<jats:p>Pulmonary hypertension (PH) can be defined as a mean pulmonary artery pressure (mPAP) greater than 20 mm Hg at rest during right heart catheterization (RHC). The reported prevalence of PH throughout the globe has been estimated to impact approximately 1% of the total population, with a majority of those afflicted being women more than men. Numerous etiologies give rise to the pathophysiology of PH, including heart disease (i.e., left-sided heart failure), lung diseases, and other unclear causes related to chronic stages and complications surrounding long-standing pulmonary thromboembolisms, side effects of certain medications, and genetic and environmental factors. Untreated PH can lead to severe morbidities such as cardio-renal syndrome and congestive hepatopathy (cardiac cirrhosis). Management of PH focuses on decreasing pulmonary pressures by using vasodilators such as prostanoids, and phosphodiesterase type 5 (PDE-5) inhibitors, as well as newer treatments such as sotatercept, which inhibits activin signaling, thereby inhibiting excessive cell growth in the pulmonary artery vasculature and down-regulating the pro-proliferative pathways.<\/jats:p>","DOI":"10.3390\/jcdd13050174","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T12:00:32Z","timestamp":1776859232000},"page":"174","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The New Era of Pulmonary Hypertension: The Dawn of Disease Modification &amp; Therapeutic Modalities"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0379-3811","authenticated-orcid":false,"given":"Noyan","family":"Ramazani","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, NV 89106, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lacey","family":"Barnes","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, NV 89106, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, NV 89106, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8966-4189","authenticated-orcid":false,"given":"Divyansh","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, NV 89106, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7247-2213","authenticated-orcid":false,"given":"Aditi","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, NV 89106, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3696-195X","authenticated-orcid":false,"given":"KaChon","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, NV 89106, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-023-00486-7","article-title":"Pulmonary hypertension","volume":"10","author":"Mocumbi","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG)","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.2022.4402","article-title":"Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review","volume":"327","author":"Ruopp","year":"2022","journal-title":"JAMA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jacasi.2022.04.008","article-title":"Pulmonary hypertension definition, classification, and epidemiology in Asia","volume":"2","author":"Anderson","year":"2022","journal-title":"JACC Asia"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S2213-2600(15)00543-3","article-title":"A global view of pulmonary hypertension","volume":"4","author":"Hoeper","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1801887","DOI":"10.1183\/13993003.01887-2018","article-title":"Pathology and pathobiology of pulmonary hypertension: State of the art and research perspectives","volume":"53","author":"Humbert","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/CIRCULATIONAHA.116.022362","article-title":"Systemic consequences of pulmonary hypertension and right-sided heart failure","volume":"141","author":"Rosenkranz","year":"2020","journal-title":"Circulation"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1002\/j.2040-4603.2022.tb00212.x","article-title":"Hepatopulmonary syndrome and portopulmonary hypertension: Pulmonary vascular complications of liver disease","volume":"12","author":"DuBrock","year":"2022","journal-title":"Compr. Physiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/s41581-024-00857-7","article-title":"Pulmonary hypertension and chronic kidney disease: Prevalence, pathophysiology and outcomes","volume":"20","author":"Zeder","year":"2024","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"101351","DOI":"10.1016\/j.cpcardiol.2022.101351","article-title":"Right Heart Catheterization (RHC): A comprehensive review of provocation tests and hepatic hemodynamics in patients with Pulmonary Hypertension (PH)","volume":"47","year":"2022","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1164\/rccm.202302-0327SO","article-title":"Pulmonary hypertension: A contemporary review","volume":"208","author":"Johnson","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41569-019-0242-x","article-title":"Molecular genetic framework underlying pulmonary arterial hypertension","volume":"17","author":"Southgate","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Welch, C.L., and Chung, W.K. (2020). Genetics and genomics of pediatric pulmonary arterial hypertension. Genes, 11.","DOI":"10.20944\/preprints202009.0073.v1"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMra2000348","article-title":"Pulmonary Arterial Hypertension","volume":"385","author":"Hassoun","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Liu, L., Li, C., Cai, J., Kong, R., Wang, Y., Wang, Y., Li, S., Zhan, J., and Liu, Y. (2024). Trends and levels of the global, regional, and national burden of pulmonary arterial hypertension from 1990 to 2021: Findings from the global burden of disease study 2021. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1515961"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e024969","DOI":"10.1161\/JAHA.121.024969","article-title":"Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry","volume":"11","author":"Chang","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1007\/s10067-022-06446-y","article-title":"Pulmonary hypertension in connective tissue diseases: Epidemiology, pathogenesis, and treatment","volume":"42","author":"Cansu","year":"2023","journal-title":"Clin. Rheumatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.semarthrit.2020.06.005","article-title":"Epidemiology and mortality of connective tissue disease-associated pulmonary arterial hypertension: A national cohort study in taiwan","volume":"50","author":"Lin","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e00080","DOI":"10.1161\/HHF.0000000000000080","article-title":"Pulmonary Hypertension in Congenital Heart Disease: A Scientific Statement From the American Heart Association","volume":"16","author":"Jone","year":"2023","journal-title":"Circulation. Heart Fail."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/joim.13468","article-title":"Management and prognosis of HIV-associated pulmonary arterial hypertension: 20 Years of evidence from the REHAP registry","volume":"292","author":"Salvador","year":"2022","journal-title":"J. Intern. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"102602","DOI":"10.1016\/j.autrev.2020.102602","article-title":"Factors associated with pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc)","volume":"19","author":"Jiang","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/art.41665","article-title":"Association of Lymphangiogenic Factors with Pulmonary Arterial Hypertension in Systemic Sclerosis","volume":"73","author":"Didriksen","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Gluschke, H., Siegert, E., Minich, W.B., Hackler, J., Riemekasten, G., Kuebler, W.M., Simmons, S., and Schomburg, L. (2022). Autoimmunity to Sphingosine-1-Phosphate-Receptors in Systemic Sclerosis and Pulmonary Arterial Hypertension. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.935787"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e36654","DOI":"10.1097\/MD.0000000000036654","article-title":"Risk factors of systemic lupus erythematosus patients with pulmonary arterial hypertension: A systematic review and meta-analysis","volume":"102","author":"Lun","year":"2023","journal-title":"Medicine"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1177\/09612033231202398","article-title":"Risk factors of pulmonary arterial hypertension in patients with systemic lupus erythematosus: A meta-analysis","volume":"32","author":"Liu","year":"2023","journal-title":"Lupus"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12931-025-03169-x","article-title":"Deciphering the transcriptomic landscape of systemic lupus erythematosus-associated pulmonary arterial hypertension","volume":"26","author":"Li","year":"2025","journal-title":"Respir. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1093\/rheumatology\/kead055","article-title":"In-depth characterization of pulmonary arterial hypertension in mixed connective tissue disease: A French national multicentre study","volume":"62","author":"Chaigne","year":"2023","journal-title":"Rheumatology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1093\/rheumatology\/keaf075","article-title":"Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD)","volume":"64","author":"Thoreau","year":"2025","journal-title":"Rheumatology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.1093\/rheumatology\/keab118","article-title":"Factors associated with incident severe pulmonary arterial hypertension in systemic autoimmune rheumatic diseases: A nationwide study","volume":"60","author":"Chen","year":"2021","journal-title":"Rheumatology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"133131","DOI":"10.1016\/j.ijcard.2025.133131","article-title":"Pulmonary hypertension in patients with Sj\u00f6gren\u2019s syndrome: Gender differences in cardiovascular risk factors and instrumental data","volume":"428","author":"Coppi","year":"2025","journal-title":"Int. J. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13075-023-03171-y","article-title":"Identification of potential susceptibility genes in patients with primary Sj\u00f6gren\u2019s syndrome-associated pulmonary arterial hypertension through whole exome sequencing","volume":"25","author":"Li","year":"2023","journal-title":"Arthritis Res. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cld.2024.03.005","article-title":"Pulmonary Complications of Portal Hypertension","volume":"28","author":"Bommena","year":"2024","journal-title":"Clin. Liver Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/17843286.2025.2456697","article-title":"Pulmonary vascular complications of cirrhosis: Hepatopulmonary syndrome and portopulmonary hypertension","volume":"79","author":"Verstraeten","year":"2024","journal-title":"Acta Clin. Belg."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e417","DOI":"10.1016\/S2666-7568(21)00116-1","article-title":"Association between HIV and incident pulmonary hypertension in US Veterans: A retrospective cohort study","volume":"2","author":"Duncan","year":"2021","journal-title":"Lancet Healthy Longev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"eabe5407","DOI":"10.1126\/scitranslmed.abe5407","article-title":"Epigenetic reactivation of transcriptional programs orchestrating fetal lung development in human pulmonary hypertension","volume":"14","author":"Chelladurai","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1161\/CIRCULATIONAHA.119.044320","article-title":"Novel mutations and decreased expression of the epigenetic regulator TET2 in pulmonary arterial hypertension","volume":"141","author":"Potus","year":"2020","journal-title":"Circulation"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"eaba2470","DOI":"10.1126\/sciadv.aba2470","article-title":"DNA methyltransferase 3B deficiency unveils a new pathological mechanism of pulmonary hypertension","volume":"6","author":"Yan","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1161\/CIRCULATIONAHA.109.916098","article-title":"Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: A basis for excessive cell proliferation and a new therapeutic target","volume":"121","author":"Archer","year":"2010","journal-title":"Circulation"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e029024","DOI":"10.1161\/JAHA.122.029024","article-title":"Revised Definition of Pulmonary Hypertension and Approach to Management: A Clinical Primer","volume":"12","author":"Maron","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"103506","DOI":"10.1016\/j.autrev.2023.103506","article-title":"Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data","volume":"23","author":"Thoreau","year":"2024","journal-title":"Autoimmun. Rev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13075-024-03338-1","article-title":"The prognosis and management of reclassified systemic lupus erythematosus associated pulmonary arterial hypertension according to 2022 ESC\/ERS guidelines","volume":"26","author":"Li","year":"2024","journal-title":"Arthritis Res. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S2213-2600(22)00097-2","article-title":"Phenotyping of idiopathic pulmonary arterial hypertension: A registry analysis","volume":"10","author":"Hoeper","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"ref_44","first-page":"560","article-title":"Heritable pulmonary arterial hypertension","volume":"65","author":"Eichstaedt","year":"2024","journal-title":"Inn. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S2213-2600(19)30480-1","article-title":"Systemic sclerosis-associated interstitial lung disease","volume":"8","author":"Perelas","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e14110","DOI":"10.1016\/j.heliyon.2023.e14110","article-title":"Association between systemic sclerosis and left ventricle dysfunction: Findings from observational studies","volume":"9","author":"Yan","year":"2023","journal-title":"Heliyon"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/art.42349","article-title":"Dynamic Prediction of Pulmonary Hypertension in Systemic Sclerosis Using Landmark Analysis","volume":"75","author":"Nihtyanova","year":"2023","journal-title":"Arthritis Rheumatol."},{"key":"ref_48","first-page":"100513","article-title":"Recent developments in connective tissue disease associated pulmonary arterial hypertension","volume":"16","author":"Rodolfi","year":"2024","journal-title":"Int. J. Cardiol. Congenit. Heart Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.hfc.2022.08.016","article-title":"Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis","volume":"19","author":"Lewis","year":"2023","journal-title":"Heart Fail. Clin."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/crj.13720","article-title":"Analysis of characteristics related to interstitial lung disease or pulmonary hypertension in patients with dermatomyositis","volume":"17","author":"Wang","year":"2023","journal-title":"Clin. Respir. J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s10741-019-09847-5","article-title":"Adult congenital heart disease with pulmonary arterial hypertension: Mechanisms and management","volume":"25","author":"Papamichalis","year":"2020","journal-title":"Heart Fail. Rev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ccm.2020.11.008","article-title":"Pulmonary Arterial Hypertension Secondary to Drugs and Toxins","volume":"42","author":"Ramirez","year":"2021","journal-title":"Clin. Chest Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MCP.0000000000000888","article-title":"Methamphetamine-associated pulmonary arterial hypertension","volume":"28","author":"Kolaitis","year":"2022","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_54","first-page":"59","article-title":"Risk factors associated with pulmonary arterial hypertension among HIV-infected adults: A meta-analysis and systematic review","volume":"24","author":"Liu","year":"2022","journal-title":"AIDS Rev."},{"key":"ref_55","first-page":"45","article-title":"Pulmonary Arterial Hypertension in Patients Infected with the Human Immunodeficiency Virus","volume":"40","author":"Hon","year":"2022","journal-title":"Cardiol. Clin."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e002318","DOI":"10.1136\/bmjresp-2024-002318","article-title":"Pulmonary hypertension survival and hospitalisations in people living with HIV: A systematic review and meta-analysis","volume":"11","author":"Youssef","year":"2024","journal-title":"BMJ Open Respir. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e1517","DOI":"10.1097\/TXD.0000000000001517","article-title":"Portopulmonary hypertension: An updated review","volume":"9","author":"Ruiz","year":"2023","journal-title":"Transplant. Direct"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"101381","DOI":"10.1016\/j.siny.2022.101381","article-title":"Pulmonary hypertension in the newborn- etiology and pathogenesis","volume":"27","author":"Sankaran","year":"2022","journal-title":"Semin. Fetal Neonatal Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/ppul.25073","article-title":"Persistent pulmonary hypertension of the newborn","volume":"56","author":"Mandell","year":"2021","journal-title":"Pediatr. Pulmonol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"108026","DOI":"10.1016\/j.rmed.2025.108026","article-title":"Schistosomiasis-associated pulmonary arterial hypertension (Sch-PAH): A comprehensive review of diagnosis and management","volume":"240","author":"Pata","year":"2025","journal-title":"Respir. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"190089","DOI":"10.1183\/16000617.0089-2019","article-title":"Schistosomiasis-associated pulmonary arterial hypertension: A systematic review","volume":"29","author":"Knafl","year":"2020","journal-title":"Eur. Respir. Rev."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.3748\/wjg.v29.i19.3040","article-title":"Pulmonary hypertension, nephrotic syndrome, and polymyositis due to hepatitis C virus infection: A case report","volume":"29","author":"Zhao","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_63","first-page":"1801897","article-title":"Pulmonary hypertension due to left heart disease","volume":"5","author":"Tedford","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/CIRCULATIONAHA.111.085761","article-title":"Pulmonary hypertension due to left heart disease","volume":"126","author":"Guazzi","year":"2012","journal-title":"Circulation"},{"key":"ref_65","first-page":"1127","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"73","author":"Humbert","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1161\/CIRCULATIONAHA.117.031608","article-title":"Global pulmonary vascular remodeling in pulmonary hypertension associated with heart failure and preserved or reduced ejection fraction","volume":"137","author":"Fayyaz","year":"2018","journal-title":"Circulation"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"833","DOI":"10.21037\/cdt-23-59","article-title":"Fluid loading during the hemodynamic evaluation of pulmonary hypertension: A cross-sectional study","volume":"23","author":"Qaiser","year":"2023","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_68","first-page":"e202006","article-title":"Group 3 pulmonary hypertension: Challenges and opportunities","volume":"2020","author":"McGettrick","year":"2020","journal-title":"Glob. Cardiol. Sci. Pract."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1161\/CIRCRESAHA.121.319970","article-title":"Group 3 pulmonary hypertension: From bench to bedside","volume":"130","author":"Singh","year":"2022","journal-title":"Circ. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1183\/09031936.00015608","article-title":"Pulmonary hypertension in COPD","volume":"32","author":"Chaouat","year":"2008","journal-title":"Eur. Respir. J."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e000137","DOI":"10.1136\/bmjmed-2022-000137","article-title":"Pathophysiology and new advances in pulmonary hypertension","volume":"2","author":"Bousseau","year":"2023","journal-title":"BMJ Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"160111","DOI":"10.1183\/16000617.0111-2016","article-title":"Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension","volume":"26","author":"Jenkins","year":"2017","journal-title":"Eur. Respir. Rev."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Al-Qadi, M., LeVarge, B., and Ford, H.J. (2021). Epidemiology, pathogenesis, and clinical approach in group 5 pulmonary hypertension. Front. Med., 7.","DOI":"10.3389\/fmed.2020.616720"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"859","DOI":"10.21037\/cdt-20-295","article-title":"The role of imaging in pulmonary hypertension","volume":"11","author":"Sharma","year":"2021","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"ITC49","DOI":"10.7326\/AITC202104200","article-title":"Pulmonary hypertension","volume":"174","author":"Poch","year":"2021","journal-title":"Ann. Intern. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"103290","DOI":"10.1016\/j.autrev.2023.103290","article-title":"The role of TAPSE\/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort","volume":"22","author":"Colalillo","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e012518","DOI":"10.1161\/CIRCHEARTFAILURE.124.012518","article-title":"TAPSE\/sPAP Ratio to Improve Risk Assessment in Pulmonary Arterial Hypertension","volume":"18","author":"Badagliacca","year":"2025","journal-title":"Circ. Heart Fail."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/pathophysiology29010012","article-title":"sPAP\/PAAT ratio as a new index of pulmonary vascular load: A study in normal subjects and ssc patients with and without PH","volume":"29","author":"Serra","year":"2022","journal-title":"Pathophysiology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2012.10.009","article-title":"Echocar-diography in pulmonary arterial hypertension: From diagnosis to prognosis","volume":"26","author":"Bossone","year":"2013","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_80","first-page":"100015","article-title":"Methods to improve the yield of right heart catheterization in pulmonary hypertension","volume":"2","author":"Arunachalam","year":"2020","journal-title":"Respir. Med. X"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1016\/j.jacc.2017.03.597","article-title":"Left main coronary artery compression in patients with pulmonary arterial hypertension and angina","volume":"69","author":"Saia","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_82","first-page":"117","article-title":"Computed tomography angiography in pulmonary hypertension","volume":"10","author":"Grubstein","year":"2008","journal-title":"Isr. Med. Assoc. J."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1007\/s00330-020-06846-1","article-title":"Diagnostic accuracy of CT pulmonary angiography in suspected pulmonary hypertension","volume":"30","author":"Swift","year":"2020","journal-title":"Eur. Radiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/1817-1737.203742","article-title":"A review of imaging modalities in pulmonary hypertension","volume":"12","author":"Ascha","year":"2017","journal-title":"Ann. Thorac. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1002\/j.2040-4603.2022.tb00229.x","article-title":"Imaging in Pulmonary Vascular Disease\u2014Understanding Right Ventricle-Pulmonary Artery Coupling","volume":"12","author":"Tsarova","year":"2022","journal-title":"Compr. Physiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/jmri.27849","article-title":"Integrated cardiopulmonary MRI assessment of pulmonary hypertension","volume":"55","author":"Saunders","year":"2022","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12968-021-00743-2","article-title":"Multimodal assessment of right ventricle overload-metabolic and clinical consequences in pulmonary arterial hypertension","volume":"23","author":"Kazimierczyk","year":"2021","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2502501","DOI":"10.1183\/13993003.02501-2025","article-title":"Multi-beat right ventricular\u2013pulmonary arterial coupling and survival in pulmonary hypertension: Are we missing the right signals?","volume":"67","author":"Yogeswaran","year":"2026","journal-title":"Eur. Respir. J."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/heartjnl-2020-316741","article-title":"Prognostic role of PET\/MRI hybrid imaging in patients with pulmonary arterial hypertension","volume":"107","author":"Kazimierczyk","year":"2021","journal-title":"Heart"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e18743064288565","DOI":"10.2174\/0118743064288565240515115239","article-title":"The role of cardiac MRI in pulmonary hypertension-Is it still an underutilized tool","volume":"18","author":"Banjade","year":"2024","journal-title":"Open Respir. Med. J."},{"key":"ref_91","first-page":"1570","article-title":"Significance of prudent discernment of 18F-FDG PET right ventricular wall uptake in sarcoidosis associated pulmonary hypertension (SAPH)","volume":"64","author":"Shokrekhuda","year":"2023","journal-title":"J. Nucl. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"15829","DOI":"10.1038\/s41598-021-95196-z","article-title":"Transcriptomic profile of cationic channels in human pulmonary arterial hypertension","volume":"11","author":"Cogolludo","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10456-023-09902-8","article-title":"Impact of heterozygous ALK1 mutations on the transcriptomic response to BMP9 and BMP10 in endothelial cells from hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension donors","volume":"27","author":"Liu","year":"2024","journal-title":"Angiogenesis"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1111\/bcp.15436","article-title":"Identifying new drugs associated with pulmonary arterial hypertension: A who pharmacovigilance database disproportionality analysis","volume":"88","author":"Hlavaty","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Butrous, G. (2025). Global Landscape of Infection-Induced Pulmonary Hypertension. Infect. Dis. Rep., 17.","DOI":"10.3390\/idr17020035"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1053\/j.jvca.2021.06.036","article-title":"Pulmonary hypertension in 2021: Part I\u2014Definition, classification, pathophysiology, and presentation","volume":"36","author":"Gelzinis","year":"2022","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Kurakula, K., Smolders, V.F., Tura-Ceide, O., Jukema, J.W., Quax, P.H., and Goumans, M.J. (2021). Endothelial dysfunction in pulmonary hypertension: Cause or consequence?. Biomedicines, 9.","DOI":"10.3390\/biomedicines9010057"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1164\/rccm.201304-0686PP","article-title":"Nitric oxide deficiency and endothelial dysfunction in Pulmonary arterial hypertension","volume":"188","author":"Klinger","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"20160745","DOI":"10.1259\/bjr.20160745","article-title":"Complications of pulmonary hypertension: A pictorial review","volume":"90","author":"Mak","year":"2017","journal-title":"Br. J. Radiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/jon.12840","article-title":"Brain structural changes in patients with pulmonary arterial hypertension","volume":"31","author":"Roy","year":"2021","journal-title":"J. Neuroimaging"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"4739803","DOI":"10.1155\/2016\/4739803","article-title":"Pulmonary artery dissection: A fatal complication of pulmonary hypertension","volume":"2016","author":"Zhang","year":"2016","journal-title":"Case Rep. Med."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Porembskaya, O., Toropova, Y., Tomson, V., Lobastov, K., Laberko, L., Kravchuk, V., Saiganov, S., and Brill, A. (2020). Pulmonary artery thrombosis: A diagnosis that strives for its independence. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21145086"},{"key":"ref_103","first-page":"392","article-title":"Postoperative pulmonary complications in contemporary cohort of patients with pulmonary hypertension","volume":"19","author":"Kruthiventi","year":"2019","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCRESAHA.113.301129","article-title":"The right ventricle in pulmonary arterial hypertension: Disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure","volume":"115","author":"Ryan","year":"2014","journal-title":"Circ. Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.pcad.2012.06.002","article-title":"Arrhythmias in pulmonary arterial hypertension","volume":"55","author":"Rajdev","year":"2012","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ijcard.2012.03.071","article-title":"QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension","volume":"167","author":"Rich","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.4187\/respcare.02252","article-title":"Complications leading to sudden cardiac death in Pulmonary arterial hypertension","volume":"58","author":"Demerouti","year":"2013","journal-title":"Respir. Care"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1086\/674302","article-title":"Pericardial Effusion in Pulmonary Arterial Hypertension","volume":"3","author":"Sahay","year":"2013","journal-title":"Pulm. Circ."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1016\/j.jacc.2017.04.047","article-title":"Left main coronary artery compression in patients with pulmonary arterial hypertension","volume":"69","author":"Alfonso","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_110","unstructured":"Kousa, O., Rout, P., Aslam, A., and Aboeata, A. (2026, February 10). Cardiorenal Syndrome, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK542305\/."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/MAJ.0b013e3181a3936f","article-title":"Pericardial and pleural effusions in congestive heart failure\u2014Anatomical, pathophysiologic, and clinical considerations","volume":"338","author":"Natanzon","year":"2009","journal-title":"Am. J. Med. Sci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.3748\/wjg.v20.i23.7312","article-title":"Pathogenesis of liver cirrhosis","volume":"20","author":"Zhou","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.amjcard.2017.04.019","article-title":"Right-sided cardiac dysfunction in heart failure with preserved ejection fraction and worsening renal function","volume":"120","author":"Mukherjee","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Gonzales, J., and Fraidenburg, D.R. (2023). Pharmacology and emerging therapies for group 3 pulmonary hypertension due to chronic lung disease. Pharmaceuticals, 16.","DOI":"10.3390\/ph16030418"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","article-title":"Predicting survival in pulmonary arterial hypertension: Insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL)","volume":"122","author":"Benza","year":"2010","journal-title":"Circulation"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.chest.2019.02.004","article-title":"Predicting survival in patients with pulmonary arterial hypertension: The REVEAL risk score calculator 2.0 and comparison with ESC\/ERS-based risk assessment strategies","volume":"156","author":"Benza","year":"2019","journal-title":"Chest"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1056\/NEJMoa1503184","article-title":"Selexipag for the treatment of pulmonary arterial hypertension","volume":"373","author":"Sitbon","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1056\/NEJMoa2024277","article-title":"Sotatercept for the treatment of pulmonary arterial hypertension","volume":"384","author":"Humbert","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_119","unstructured":"U.S. Food and Drug Administration (2026, February 16). FDA approves sotatercept (WINREVAIR) for pulmonary arterial hypertension, FDA Drug Approval Snapshot, Available online: https:\/\/www.fda.gov."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e1079","DOI":"10.1002\/iid3.1079","article-title":"Idiopathic pulmonary fibrosis: Addressing the current and future therapeutic advances along with the role of Sotatercept in the management of pulmonary hypertension","volume":"11","author":"Hadi","year":"2023","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/heart.90.1.69","article-title":"Atrial septostomy in the treatment of severe pulmonary arterial hypertension","volume":"90","author":"Reichenberger","year":"2004","journal-title":"Heart"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Desai, A., and Desouza, S.A. (2017). Treatment of pulmonary hypertension with left heart disease: A concise review. Vasc. Health Risk Manag., 415\u2013420.","DOI":"10.2147\/VHRM.S111597"},{"key":"ref_123","first-page":"100571","article-title":"New therapies in pulmonary arterial hypertension: Recent insights","volume":"19","author":"Guglielmi","year":"2025","journal-title":"Int. J. Cardiol. Congenit. Heart Dis."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41569-024-01064-4","article-title":"Mechanisms and treatment of pulmonary arterial hypertension","volume":"22","author":"Ghofrani","year":"2025","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Golden, L., and Rogers, J.G. (2022). Heart Failure Drug Therapy: New Treatments, New Guidelines. Tex. Heart Inst. J., 49.","DOI":"10.14503\/THIJ-22-7920"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0002-8703(97)70105-4","article-title":"A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)","volume":"134","author":"Califf","year":"1997","journal-title":"Am. Heart J."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cardfail.2007.11.006","article-title":"Effects of 5\u2032-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: A double-blind, placebo-controlled clinical trial","volume":"14","author":"Behling","year":"2008","journal-title":"J. Card. Fail."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.110.983866","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction: A target of phosphodiesterase-5 inhibition in a 1-year study","volume":"124","author":"Guazzi","year":"2011","journal-title":"Circulation"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.carrev.2025.05.022","article-title":"Right ventricular-pulmonary arterial coupling in transcatheter structural heart interventions","volume":"78","author":"Theofilis","year":"2025","journal-title":"Cardiovasc. Revascularization Med."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMoa2008470","article-title":"Inhaled treprostinil in pulmonary hypertension due to interstitial lung disease","volume":"384","author":"Waxman","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"(2010). Idiopathic Pulmonary Fibrosis Clinical Research Network. A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. N. Engl. J. Med., 363, 620\u2013628.","DOI":"10.1056\/NEJMoa1002110"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S2213-2600(20)30356-8","article-title":"Efficacy and safety of sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A double-blind, randomised, placebo-controlled, phase 2b trial","volume":"9","author":"Behr","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.chest.2020.02.016","article-title":"A randomized, double-blind, placebo-controlled study of pulsed, inhaled nitric oxide in subjects at risk of pulmonary hypertension associated with pulmonary fibrosis","volume":"158","author":"Nathan","year":"2020","journal-title":"Chest"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1513\/AnnalsATS.202110-1160ED","article-title":"Inhaled nitric oxide for fibrotic interstitial lung disease: A step forward","volume":"19","author":"Khor","year":"2022","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S2213-2600(19)30250-4","article-title":"Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): A randomised, placebo-controlled phase 2b study","volume":"7","author":"Nathan","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1900585","DOI":"10.1183\/13993003.00585-2019","article-title":"Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease","volume":"54","author":"Savale","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1086\/687291","article-title":"Resolution of myelofibrosis-associated pulmonary arterial hypertension following allogeneic hematopoietic stem cell transplantation","volume":"6","author":"Faiz","year":"2016","journal-title":"Pulm. Circ."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/leu.2014.5","article-title":"Ruxolitinib leads to improvement of pulmonary hypertension in patients with myelofibrosis","volume":"28","author":"Tabarroki","year":"2014","journal-title":"Leukemia"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1046\/j.1365-2141.2002.03695.x","article-title":"Low-dose, single-fraction, whole-lung radiotherapy for pulmonary hypertension associated with myelofibrosis with myeloid metaplasia","volume":"118","author":"Steensma","year":"2002","journal-title":"Br. J. Haematol."}],"container-title":["Journal of Cardiovascular Development and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3425\/13\/5\/174\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T12:37:39Z","timestamp":1776861459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3425\/13\/5\/174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":139,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["jcdd13050174"],"URL":"https:\/\/doi.org\/10.3390\/jcdd13050174","relation":{},"ISSN":["2308-3425"],"issn-type":[{"value":"2308-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]}}}